IQVIA stock climbs as analysts keep a moderate buy

IQVIA stock is backed by a $241.88 average target, a $2 billion buyback and fiscal 2026 EPS guidance of $12.80 to $13.00.

IQVIA Holdings (US46266C1053) is trading with a $42.82 billion market value and a consensus target of $241.88 as analysts kept a moderate buy view on August 24, 2026. The same review also pointed to $3.15 in quarterly EPS, $4.37 billion in revenue and fiscal 2026 EPS guidance of $12.80 to $13.00.

Analysts stay constructive

The latest broker summary showed 13 buy ratings, three holds and one strong-buy rating, with the average target still at $241.88. That sits beside a $260.17 opening price cited in the same market snapshot, while the 52-week range ran from $154.50 to $260.40.

For investors, the key number is the spread between the $241.88 target and the current $260.17 level in the same report, because it frames how much optimism is already reflected in the share price. The market also had a clean comparison point from the last quarter: revenue rose 8.7% year over year to $4.37 billion.

Guidance and last quarter

IQVIA's most recent quarterly results came on July 28, 2026, when EPS reached $3.15, topping the $3.03 consensus by $0.12. Revenue also beat expectations of $4.30 billion, and the company said fiscal 2026 EPS should land between $12.80 and $13.00.

The buyback adds another layer. IQVIA authorized a $2 billion share-repurchase program on May 7, 2026, a move that can support per-share math if execution continues through the year.

IQVIA services mix

IQVIA's business spans contract research, real-world evidence, analytics and technology tools for life sciences customers. That mix matters because the July 28, 2026 quarter showed both higher revenue and a 30.25% return on equity in the same earnings snapshot.

Shares and market value

As of August 24, 2026, IQVIA's market cap stood at $42.82 billion in the same market data set. The share price opened at $260.17, while the 52-week low was $154.50 and the high was $260.40.

More on IQVIA stock

MarketBeat's August 24, 2026 summary tied the stock to a moderate buy consensus and a $241.88 average target. That leaves investors weighing a strong first-half run against the latest earnings beat and the new $2 billion repurchase authorization.

Fact box

Company: IQVIA Holdings Inc.
ISIN: US46266C1053
Ticker: IQV
Exchange: NYSE
Price (as of August 24, 2026, 9:30 a.m. ET): $260.17 USD
Market cap: $42.82 billion
Sector / Industry: Health Care / Life Sciences Tools & Services